BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27268630)

  • 1. Ki-67 Immunostaining and its Correlation with Microvessel Density in Patients with Mutiple Myeloma.
    Himani B; Meera S; Abhimanyu S; Usha R
    Asian Pac J Cancer Prev; 2016; 17(5):2559-64. PubMed ID: 27268630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters.
    Bhatti SS; Kumar L; Dinda AK; Dawar R
    Am J Hematol; 2006 Sep; 81(9):649-56. PubMed ID: 16845660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of VEGF and microvessel density in patients with multiple myeloma: clinical and prognostic significance.
    Marković O; Marisavljević D; Cemerikić V; Vidović A; Perunicić M; Todorović M; Elezović I; Colović M
    Med Oncol; 2008; 25(4):451-7. PubMed ID: 18449811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow angiogenesis and its correlation with other disease characteristics in multiple myeloma in stage I versus stage II-III.
    Niemöller K; Jakob C; Heider U; Zavrski I; Eucker J; Kaufmann O; Possinger K; Sezer O
    J Cancer Res Clin Oncol; 2003 Apr; 129(4):234-8. PubMed ID: 12700896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse prognostic impact of bone marrow microvessel density in multiple myeloma.
    Lee N; Lee H; Moon SY; Sohn JY; Hwang SM; Yoon OJ; Youn HS; Eom HS; Kong SY
    Ann Lab Med; 2015 Nov; 35(6):563-9. PubMed ID: 26354343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ki-67 proliferation index: correlation with prognostic parameters and outcome in multiple myeloma.
    Alexandrakis MG; Passam FH; Kyriakou DS; Dambaki K; Niniraki M; Stathopoulos E
    Am J Clin Oncol; 2004 Feb; 27(1):8-13. PubMed ID: 14758126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow microvascular density and angiogenic growth factors in multiple myeloma.
    Alexandrakis MG; Passam FJ; Ganotakis E; Dafnis E; Dambaki C; Konsolas J; Kyriakou DS; Stathopoulos E
    Clin Chem Lab Med; 2004; 42(10):1122-6. PubMed ID: 15552270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between bone marrow angiogenesis and plasma cell infiltration and serum beta2-microglobulin levels in patients with multiple myeloma.
    Sezer O; Niemöller K; Jakob C; Zavrski I; Heider U; Eucker J; Kaufmann O; Possinger K
    Ann Hematol; 2001 Oct; 80(10):598-601. PubMed ID: 11732871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow angiogenesis in multiple myeloma and its correlation with clinicopathological factors.
    Rana C; Sharma S; Agrawal V; Singh U
    Ann Hematol; 2010 Aug; 89(8):789-94. PubMed ID: 20177896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.
    Rajkumar SV; Mesa RA; Fonseca R; Schroeder G; Plevak MF; Dispenzieri A; Lacy MQ; Lust JA; Witzig TE; Gertz MA; Kyle RA; Russell SJ; Greipp PR
    Clin Cancer Res; 2002 Jul; 8(7):2210-6. PubMed ID: 12114422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of angiogenesis and Ki-67, p53, and p21 expression: a population-based endometrial carcinoma study.
    Salvesen HB; Iversen OE; Akslen LA
    J Clin Oncol; 1999 May; 17(5):1382-90. PubMed ID: 10334522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of bone marrow microvessel density and angiogenic cytokines in patients with multiple myeloma undergoing autologous stem cell transplant.
    Sucak GT; Aki SZ; Yüzbaşioğlu B; Akyürek N; Yağci M; Bağriaçik U; Haznedar R
    Leuk Lymphoma; 2011 Jul; 52(7):1281-9. PubMed ID: 21599578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of platelet-derived growth factor-AB in tumour growth and angiogenesis in relation with other angiogenic cytokines in multiple myeloma.
    Tsirakis G; Pappa CA; Kanellou P; Stratinaki MA; Xekalou A; Psarakis FE; Sakellaris G; Alegakis A; Stathopoulos EN; Alexandrakis MG
    Hematol Oncol; 2012 Sep; 30(3):131-6. PubMed ID: 21919032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrences in stage II rectal carcinoma after curative resection alone: from the viewpoint of angiogenesis.
    Martinović Ž; Kovač D; Martinović C
    World J Surg Oncol; 2016 Apr; 14():122. PubMed ID: 27102733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of proliferating cell nuclear antigen (PCNA) in multiple myeloma: its relationship to bone marrow microvessel density and other factors of disease activity.
    Alexandrakis MG; Passam FH; Pappa CA; Dambaki C; Sfakiotaki G; Alegakis AK; Kyriakou DS; Stathopoulos E
    Int J Immunopathol Pharmacol; 2004; 17(1):49-56. PubMed ID: 15000866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microvessel density assessment in benign and malignant endometrial changes.
    Czekierdowski A; Czekierdowska S; Czuba B; Cnota W; Sodowski K; Kotarski J; Zwirska-Korczala K
    J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():45-51. PubMed ID: 18955753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relation between bone marrow angiogenesis and the proliferation index Ki-67 in multiple myeloma.
    Alexandrakis MG; Passam FH; Dambaki C; Pappa CA; Stathopoulos EN
    J Clin Pathol; 2004 Aug; 57(8):856-60. PubMed ID: 15280408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microvessel density and Ki-67 labeling index in esthesioneuroblastoma: is there a prognostic role?
    Singh L; Ranjan R; Madan R; Arava SK; Deepak RK; Singh MK
    Ann Diagn Pathol; 2015 Dec; 19(6):391-6. PubMed ID: 26343569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical expression of endoglin offers a reliable estimation of bone marrow neoangiogenesis in multiple myeloma.
    Alexandrakis MG; Neonakis IK; Pappa CA; Konsolas I; Kokonozaki M; Vyzoukaki R; Soundoulounaki S; Xekalou A; Sfiridaki K; Tsirakis G
    J Cancer Res Clin Oncol; 2015 Aug; 141(8):1503-9. PubMed ID: 25773125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease of bone marrow angiogenesis in myeloma patients achieving a remission after chemotherapy.
    Sezer O; Niemöller K; Kaufmann O; Eucker J; Jakob C; Zavrski I; Possinger K
    Eur J Haematol; 2001 Apr; 66(4):238-44. PubMed ID: 11380603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.